Question: What year was the pharmaceutical company that markets Mylotarg purchased by Pfizer?
Sentence (from "Gemtuzumab ozogamicin"): It was withdrawn from market in June 2010 when a clinical trial showed the drug increased patient death and added no benefit over conventional cancer therapies.
Relevant evidence: No